These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Final height outcome in girls with Turner syndrome treated with a combination of low dose oestrogen and oxandrolone. Bareille P; Massarano AA; Stanhope R Eur J Pediatr; 1997 May; 156(5):358-62. PubMed ID: 9177976 [TBL] [Abstract][Full Text] [Related]
8. Favorable final height outcome in girls with Ullrich-Turner syndrome treated with low-dose growth hormone together with oxandrolone despite starting treatment after 10 years of age. Stahnke N; Keller E; Landy H; J Pediatr Endocrinol Metab; 2002 Feb; 15(2):129-38. PubMed ID: 11874177 [TBL] [Abstract][Full Text] [Related]
9. Combined therapy with growth hormone and oxandrolone in adolescent girls with Turner syndrome. Lu PW; Cowell CT J Paediatr Child Health; 1993 Feb; 29(1):40-2. PubMed ID: 8461179 [TBL] [Abstract][Full Text] [Related]
10. Growth promotion and Turner-specific bone age after therapy with growth hormone and in combination with oxandrolone: when should therapy be started in Turner syndrome? Joss EE; Mullis PE; Werder EA; Partsch CJ; Sippell WG Horm Res; 1997; 47(3):102-9. PubMed ID: 9050948 [TBL] [Abstract][Full Text] [Related]
11. Six-year results of a randomized, prospective trial of human growth hormone and oxandrolone in Turner syndrome. Rosenfeld RG; Frane J; Attie KM; Brasel JA; Burstein S; Cara JF; Chernausek S; Gotlin RW; Kuntze J; Lippe BM J Pediatr; 1992 Jul; 121(1):49-55. PubMed ID: 1625092 [TBL] [Abstract][Full Text] [Related]
12. Methionyl human growth hormone and oxandrolone in Turner syndrome: preliminary results of a prospective randomized trial. Rosenfeld RG; Hintz RL; Johanson AJ; Brasel JA; Burstein S; Chernausek SD; Clabots T; Frane J; Gotlin RW; Kuntze J J Pediatr; 1986 Dec; 109(6):936-43. PubMed ID: 3537249 [TBL] [Abstract][Full Text] [Related]
13. Growth hormone in combination with anabolic steroids in patients with Turner syndrome: effect on bone maturation and final height. Haeusler G; Schmitt K; Blümel P; Plöchl E; Waldhör T; Frisch H Acta Paediatr; 1996 Dec; 85(12):1408-14. PubMed ID: 9001649 [TBL] [Abstract][Full Text] [Related]
15. Growth hormone therapy in Turner's syndrome. Impact of injection frequency and initial bone age. Rongen-Westerlaken C; van Es A; Wit JM; Otten BJ; De Muinck Keizer-Schrama SM; Drayer NM; Oostdijk W; Delemarre-vd Waal HA; Gons MH; Waelkens JJ Am J Dis Child; 1992 Jul; 146(7):817-20. PubMed ID: 1496949 [TBL] [Abstract][Full Text] [Related]
16. Growth hormone therapy in Turner's syndrome: an update on final height. Genentech National Cooperative Study Group. Rosenfeld RG Acta Paediatr Suppl; 1992 Sep; 383():3-6; discussion 7. PubMed ID: 1458013 [TBL] [Abstract][Full Text] [Related]
17. Oxandrolone in girls with Turner's syndrome. A pair-matched controlled study up to final height. Joss E; Zuppinger K Acta Paediatr Scand; 1984 Sep; 73(5):674-9. PubMed ID: 6385611 [TBL] [Abstract][Full Text] [Related]